Neurosense Therapeutics Share Price (NASDAQ: NRSN)
$1.07
Last updated on
Check the interactive Neurosense Therapeutics Stock chart to analyse performance
Neurosense Therapeutics stock performance
as on August 30, 2025 at 1:28 am IST
- Today's Low:$1.05Today's High:$1.10
2.34%
Downside
Day's Volatility :5.0%
Upside
2.73%
- 52 Weeks Low:$0.7352 Weeks High:$2.60
31.78%
Downside
52 Weeks Volatility :71.92%
Upside
58.85%
Neurosense Therapeutics Stock Returns
Neurosense Therapeutics Ltd Key Stats
Check Neurosense Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Neurosense Therapeutics Stock including INR - Dollar returns
The Neurosense Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neurosense Therapeutics investment value today
Current value as on today
₹1,14,468
Returns
₹14,468
(+14.47%)
Returns from Neurosense Therapeutics Stock
₹9,184 (+9.18%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Neurosense Therapeutics Stock
Global Institutional Holdings in Neurosense Therapeutics Ltd
Name
Holdings %
Morgan Stanley - Brokerage Accounts
0.21%
Squarepoint Ops LLC
0.20%
Meitav Dash Investments Ltd
0.16%
Commonwealth Equity Services Inc
0.07%
Geode Capital Management, LLC
0.06%
TWO SIGMA SECURITIES, LLC
0.06%
Analyst Recommendation on Neurosense Therapeutics Stock
Buy
87%Buy
12%Hold
0%Sell
Based on 8 Wall street analysts offering stock ratings for Neurosense Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Neurosense Therapeutics Share Price Target
What analysts predicted
Upside of 904.67%
Target:
$10.75
Current:
$1.07
Neurosense Therapeutics share price target is $10.75, a slight Upside of 904.67% compared to current price of $1.07 as per analysts' prediction.
Neurosense Therapeutics Stock Insights
Price Movement
In the last 7 days, NRSN stock has moved down by -8.8%NRSN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 49.7%NRSN vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 158.8%
Neurosense Therapeutics Technicals Summary
Sell
Neutral
Buy
Neurosense Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Neurosense Therapeutics Ltd Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -40.56% | 1.9% | 9.21% | -45.13% | -73.51% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.4 | -24.78 | -3.04 | NA | -0.02 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $28.5M | -73.51% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Neurosense Therapeutics Ltd
Key Management of Neurosense Therapeutics Ltd
Important FAQs about investing in NRSN Stock from India :
What is Neurosense Therapeutics share price today?
Neurosense Therapeutics share price today is $1.07 as on at the close of the market. Neurosense Therapeutics share today touched a day high of $1.10 and a low of $1.05.
What is the 52 week high and 52 week low for Neurosense Therapeutics share?
Neurosense Therapeutics share touched a 52 week high of $2.60 and a 52 week low of $0.73. Neurosense Therapeutics stock price today i.e. is closed at $1.07, lower by 58.85% versus the 52 week high.
How to invest in Neurosense Therapeutics Stock (NRSN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurosense Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurosense Therapeutics Shares that will get you 1.4019 shares as per Neurosense Therapeutics share price of $1.07 per share as on August 30, 2025 at 1:28 am IST.
What is the minimum amount required to buy Neurosense Therapeutics Stock (NRSN) from India?
Indian investors can start investing in Neurosense Therapeutics (NRSN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Neurosense Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Neurosense Therapeutics share’s latest price of $1.07 as on August 30, 2025 at 1:28 am IST, you will get 9.3458 shares of Neurosense Therapeutics. Learn more about
fractional shares .
What are the returns that Neurosense Therapeutics has given to Indian investors in the last 5 years?
Neurosense Therapeutics stock has given -73.51% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%